On-Demand Video

Video library featuring critical insights and knowledge
on global Innovative Contracting, VBA, Market Access and Human Performance Factors

Innovative Contracting & VBA
On-Demand Webinars and Masterclasses

South Korea: The evolution of risk-share agreements (RSA)
WEBINAR Verpora WEBINAR Verpora

South Korea: The evolution of risk-share agreements (RSA)

South Korea has recently shown enthusiasm towards innovative contracting and risk-sharing agreements in healthcare, with the National Health Insurance Service actively discussing a more adaptive framework. A notable global influence in these discussions is the UK's NICE International institution, which is extending its reach beyond European markets, offering infrastructure capability development and sharing methodologies with countries like South Korea. As a result, South Korea is adapting and evolving its contracting models, particularly in oncology, to better fit its market while also benefiting from the expertise of international institutions like NICE.

Read More
Turkey: The impact of the alternative reimbursement legislation
WEBINAR Verpora WEBINAR Verpora

Turkey: The impact of the alternative reimbursement legislation

Turkey's new alternative reimbursement legislation aims to modernize its healthcare sector by promoting innovative contracting. It eases interactions with international pharmaceutical companies, ensures price confidentiality, and expedites product launches. However, Omar notes that companies are turning to these alternative methods due to challenges with Turkey's traditional reimbursement model, including high discounting rates. This shift is driving companies to develop more innovative contracting proposals for this alternative route.

Read More
England: New Free of Charge (FoC) medicine guidelines
WEBINAR Verpora WEBINAR Verpora

England: New Free of Charge (FoC) medicine guidelines

In recent months, England introduced guidelines for free-of-charge medicine schemes to ensure consistency across integrated care systems. These guidelines aim to prevent distorted geographical prescribing patterns. Omar, with extensive experience in the UK, recalls some companies offering free medicines until NICE evaluations were completed, leading to tensions between clinicians and payers over potential future liabilities. The new guidelines aim to prevent localised free-of-charge offers, but keeps the door open for manufacturers to offer national national schemes.

Read More
Spain: Is this the end for IPT plans?
WEBINAR Verpora WEBINAR Verpora

Spain: Is this the end for IPT plans?

Spain's plans to consolidate its IPT assessment arrangements faced delays due to legal challenges, reflecting difficulties in changing infrastructure. The intention was to introduce a formal economic analysis combined with clinical appraisals, similar to other established models. However, despite setbacks, there remains a shift towards emphasizing cost-effectiveness data and exploring innovative contracting, like risk-sharing outcome-based agreements, for medicines in Spain.

Read More